>
Hvivo logo

HVO - Hvivo Share Price

16.5p -0.9  -5.0%

Last Trade - 17/01/20

Sector
Healthcare
Size
Micro Cap
Market Cap £n/a
Enterprise Value £n/a
Revenue £12.1m
Position in Universe th / 1819
Bullish
Bearish
Unlock HVO Revenue
Momentum
Relative Strength (%)
1m +30.4%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2013 2014 2015 2016 2017 2018 2019E 2020E CAGR / Avg
27.5 18.5 7.72 19.9 10.9 11.0 14.0 18.0 -16.7%
+110.7
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the six months ended 30 June 2019, Hvivo PLCrevenues increased 22% to £5.9M. Net loss decreased 13% to£3.8M. Revenues reflect an increase in demand for theCompany's products and services due to favorable marketconditions. Lower net loss reflects Research anddevelopment expense decrease of 60% to £1.1M (expense),Administrave expense decrease of 22% to £3.8M (expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

HVO Revenue Unlock HVO Revenue

Net Income

HVO Net Income Unlock HVO Revenue

Normalised EPS

HVO Normalised EPS Unlock HVO Revenue

PE Ratio Range

HVO PE Ratio Range Unlock HVO Revenue

Dividend Yield Range

HVO Dividend Yield Range Unlock HVO Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
HVO EPS Forecasts Unlock HVO Revenue
Profile Summary

hVIVO plc, formerly Retroscreen Virology Group plc, is a holding company. The Company is engaged in a life sciences business pioneering a technology platform of human disease models to accelerate drug discovery and development in respiratory and infectious diseases, including flu, respiratory syncytial virus (RSV), asthma and common cold. It has commercialized approximately four disease models, enrolled over 2,000 subjects and conducted approximately 40 product validation studies for a range of industry, government and academic clients and collaborators. The Company offers services, such as challenge study services, lab services, and target and biomarker discovery. It offers viral challenge studies in healthy volunteers in influenza, human rhinovirus (HRV) and RSV. Its lab services include assay development, transfer and optimization across the immunological, molecular and cell-based assay platforms, including offering options in sample matrix testing and specialty biomarker assays.

Directors
Last Annual December 31st, 2018
Last Interim June 30th, 2019
Incorporated March 27, 2012
Public Since May 3, 2012
No. of Shareholders: n/a
No. of Employees: 139
Sector Healthcare
Industry Healthcare Providers & Services
Index
Exchange London Stock Exchange
Shares in Issue 83,664,276
Free Float (0.0%)
Eligible for
ISAs
SIPPs
HVO Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for HVO
Upcoming Events for HVO
Frequently Asked Questions for Hvivo
What is the Hvivo share price?

As of 17/01/20, shares in Hvivo are trading at 16.5p, giving the company a market capitalisation of £n/a. This share price information is delayed by 15 minutes.

How has the Hvivo share price performed this year?

Shares in Hvivo are currently trading at 16.5p and the price has moved by -43.1% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Hvivo price has moved by -54.49% over the past year.

What are the analyst and broker recommendations for Hvivo?

Of the analysts with advisory recommendations for Hvivo, there are there are currently 1 "buy" , 0 "hold" and 0 "sell" recommendations. The overall consensus recommendation for Hvivo is Strong Buy. You can view the full broker recommendation list by unlocking its StockReport.

When will Hvivo next release its financial results?

Hvivo is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2020-06-30
What is the Hvivo dividend yield?

Hvivo does not currently pay a dividend.

Does Hvivo pay a dividend?

Hvivo does not currently pay a dividend.

When does Hvivo next pay dividends?

Hvivo does not currently pay a dividend.

How do I buy Hvivo shares?

To buy shares in Hvivo you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Hvivo?

Shares in Hvivo are currently trading at 16.5p, giving the company a market capitalisation of £n/a.

Where are Hvivo shares listed? Where are Hvivo shares listed?

Here are the trading details for Hvivo:

Country of listing: United Kingdom
Exchange: LSE
Ticker Symbol: HVO
What kind of share is Hvivo?

We were not able to load our ranking data for Hvivo

Is there a Hvivo share price forecast 2021?

We were not able to load any forecast data for Hvivo.

How can I tell whether the Hvivo share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Hvivo. Over the past six months, the relative strength of its shares against the market has been -32.35%. At the current price of 16.5p, shares in Hvivo are trading at % against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Hvivo PE Ratio?

We were not able to find PE ratio data for Hvivo.

Who are the key directors of Hvivo?

We were unable to find the directors for Hvivo.

Who are the major shareholders of Hvivo?

Here are the top five shareholders of Hvivo based on the size of their shareholding:

Similar to HVO
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.